The Original Investigation titled “Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-Risk or Intermediate-Risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial,”1 was originally published under the incorrect title of “Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.” This article was corrected online.
References
- 1.Shore ND, Renzulli J, Fleshner NE, et al. Enzalutamide monotherapy vs active surveillance in patients with low-risk or intermediate-risk localized prostate cancer: the ENACT randomized clinical trial. JAMA Oncol. Published online June 16, 2022. doi: 10.1001/jamadermatol.2022.1641 [DOI] [PMC free article] [PubMed] [Google Scholar]